Sun Pharma up 4% as US arm's Taro Pharma resolves antitrust investigation
Read more about Sun Pharma up 4% as US arm's Taro Pharma resolves antitrust investigation on Business Standard. Taro Pharma has reached a settlement agreement with the US Department of Justice, Antitrust and Civil divisions to pay more than $200 million to settle the generic drug price fixing allegations
Sun Pharma up 4% as US arm's Taro Pharma resolves antitrust investigation
Read more about Sun Pharma up 4% as US arm's Taro Pharma resolves antitrust investigation on Business Standard. Taro Pharma has reached a settlement agreement with the US Department of Justice, Antitrust and Civil divisions to pay more than $200 million to settle the generic drug price fixing allegations